These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29085970)

  • 41. [The physician caught between two chairs. Comments on the difficulty in dealing with off-label use].
    Harder Yv
    Urologe A; 2007 Oct; 46(10):1429-34. PubMed ID: 17786403
    [No Abstract]   [Full Text] [Related]  

  • 42. [Anthroposophic treatment in pediatrics--a critical analysis].
    Burkhard B
    Versicherungsmedizin; 2004 Dec; 56(4):197-9. PubMed ID: 15633774
    [No Abstract]   [Full Text] [Related]  

  • 43. [Limited prescribing freedom by federal cost regulation?].
    Lasek R
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):633-5. PubMed ID: 9527458
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Legislative forum ... Comprehensive HIV Prevention Act of 1993.
    Berry K
    J Healthc Qual; 1993; 15(4):38. PubMed ID: 10128804
    [No Abstract]   [Full Text] [Related]  

  • 45. Compendium of Measures to Prevent Disease Associated with Animals in Public Settings, 2017.
    ; Daly RF; House J; Stanek D; Stobierski MG
    J Am Vet Med Assoc; 2017 Dec; 251(11):1268-1292. PubMed ID: 29154705
    [No Abstract]   [Full Text] [Related]  

  • 46. The "dangerous" infected patient. An approach to characterizing the risks posed by persons with communicable infectious diseases.
    Goodman RA
    J Leg Med; 2009; 30(1):13-26. PubMed ID: 19241271
    [No Abstract]   [Full Text] [Related]  

  • 47. ["Off-label use" of botulinum toxin preparations in treatment of spasmodic dysphonia. Position of the German Society of Phoniatrics and Pediatric Audiology].
    Ptok M; Schönweiler R; Nawka T;
    HNO; 2004 Jan; 52(1):45-9. PubMed ID: 14740114
    [No Abstract]   [Full Text] [Related]  

  • 48. [MSD executive calls for more transparency and expertise. 9 out of 10 innovations fail due to a too brief value assessment (interview by Wolfgang van den Bergh, Dirk Einecke and Cornelius Heyer)].
    Quodt H
    MMW Fortschr Med; 2011 Jan; 153(4):10. PubMed ID: 22165606
    [No Abstract]   [Full Text] [Related]  

  • 49. [The pediatric drug initiative].
    Krankenpfl J; 2005; 43(7-10):218-9. PubMed ID: 16515290
    [No Abstract]   [Full Text] [Related]  

  • 50. [Robert Koch's contribution to the development of disinfection and current main points of disinfection in research and practice].
    Weuffen W
    Z Gesamte Hyg; 1982 Mar; 28(3):167-71. PubMed ID: 7048757
    [No Abstract]   [Full Text] [Related]  

  • 51. [Sewage disinfection schemes for communicable disease hospitals].
    Mel'nikova MIa; Iakimova VG; Levitskiĭ LN; Takhistov VA; Safina LS
    Gig Sanit; 1979 Jun; (6):73-4. PubMed ID: 468007
    [No Abstract]   [Full Text] [Related]  

  • 52. Flooding and communicable diseases fact sheet.
    Wkly Epidemiol Rec; 2005 Jan; 80(3):21-8. PubMed ID: 15715138
    [No Abstract]   [Full Text] [Related]  

  • 53. When global health is local health. Infectious diseases travel easily.
    Katz JR; Hirsch AM
    Am J Nurs; 2003 Dec; 103(12):75-9. PubMed ID: 14702570
    [No Abstract]   [Full Text] [Related]  

  • 54. [The 12th German Drug Law (AMG) amendment: an obstruction for non-commercial clinical trials?].
    Schwarz S; Frölich L; Striebel JP; Hennerici MG
    Dtsch Med Wochenschr; 2007 Jan; 132(3):108-12. PubMed ID: 17219346
    [No Abstract]   [Full Text] [Related]  

  • 55. [Off-label use of drugs--the legal framework].
    Koyuncu A
    Dtsch Med Wochenschr; 2012 Jul; 137(30):1519-23. PubMed ID: 22869512
    [No Abstract]   [Full Text] [Related]  

  • 56. [Routine disinfection measures in community facilities].
    Schwedes J
    Offentl Gesundheitswes; 1987 Jun; 49(6):302-4. PubMed ID: 2956547
    [No Abstract]   [Full Text] [Related]  

  • 57. [Health services research: essential for allocation decisions - joint statement].
    Pfaff H; Abholz H; Glaeske G; Icks A; Klinkhammer-Schalke M; Nellessen-Martens G; Neugebauer EA; Ohmann C; Schrappe M; Selbmann HK; Stemmer R;
    Dtsch Med Wochenschr; 2011 Dec; 136(48):2496-500. PubMed ID: 21993809
    [No Abstract]   [Full Text] [Related]  

  • 58. [Pharmacist can no longer substitute all medications].
    Zimmermann GW
    MMW Fortschr Med; 2014 Nov; 156 Spec no 2():10. PubMed ID: 25551996
    [No Abstract]   [Full Text] [Related]  

  • 59. [Legal boundaries of negative and positive lists].
    Arndt M
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):630-2. PubMed ID: 9527457
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Screening of infectious diseases].
    Leinikki P; Eskola J
    Duodecim; 2000; 116(8):887-92. PubMed ID: 11787132
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.